39.07Open39.07Pre Close0 Volume0 Open Interest121.00Strike Price0.00Turnover149.63%IV0.62%PremiumAug 30, 2024Expiry Date38.56Intrinsic Value100Multiplier4DDays to Expiry0.51Extrinsic Value100Contract SizeAmericanOptions Type-0.9916Delta0.0027Gamma2.14Leverage Ratio-0.0150Theta-0.0046Rho-2.12Eff Leverage0.0020Vega
Fomo Mofo : we all saw the webinar. for a company with 18 employees id say they are doing really well. let's hope the stock gods smile upon us on Monday with some official good news
Ken Griffin Charity2 : Why not provide the source? GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox This press release was published 19 December 2023.
Geovax has been working on a covid vaccine for the past 4 years. There is still no approved covid vaccine, much less one for mpox.